tiprankstipranks
Trending News
More News >
Mexan Limited (HK:0022)
:0022
Hong Kong Market

Mexan (0022) AI Stock Analysis

Compare
1 Followers

Top Page

HK:0022

Mexan

(0022)

Select Model
Select Model
Select Model
Neutral 47 (OpenAI - 5.2)
Rating:47Neutral
Price Target:
HK$0.20
▼(-4.76% Downside)
The score is primarily held back by weak financial performance, led by a sharp revenue decline and persistent losses. Technicals provide some offset with mildly constructive longer-term positioning and neutral-to-slightly positive momentum. Valuation remains constrained by negative earnings and the lack of a dividend yield.
Positive Factors
Diversified Revenue Model
A diversified go-to-market mix across OEM contracts, aftermarket channels and JVs reduces single-customer concentration risk and smooths revenue volatility. Long-term OEM contracts provide predictable order flow and JVs support product development, aiding stable mid-term cash generation.
Free Cash Flow Improvement
Improving free cash flow despite losses indicates operational cash conversion resilience. Sustained positive FCF allows reinvestment in R&D and capex, funds debt servicing and supports strategic initiatives, giving the company more optionality to pursue long-term recovery and product development.
Manageable Leverage
A moderate leverage profile with a stable equity base preserves financial flexibility, reducing refinancing and solvency risk during cyclical downturns. This balance sheet posture supports continued investment in operations and cushions execution while management addresses profitability.
Negative Factors
Severe Revenue Decline
A three-quarter magnitude revenue drop signals structural demand or contract losses, undermining scale economics and fixed-cost absorption. Persistent top-line contraction erodes market position, weakens supplier and customer relationships, and makes recovery reliant on sustained new contract wins.
Ongoing Profitability Losses
Repeated negative EBIT and net income imply inability to convert revenue into sustainable profits. This undermines reinvestment capacity and returns to equity holders, risks further equity dilution or cost-cutting, and may impede long-term competitiveness without structural margin improvement.
Weak Cash Quality vs. Earnings
A discordant operating cash flow to net income ratio suggests earnings quality issues and potential working capital strains. If cash generation lags reported results, the firm may face tighter liquidity under stress, limiting its ability to fund operations, capex, or strategic initiatives long term.

Mexan (0022) vs. iShares MSCI Hong Kong ETF (EWH)

Mexan Business Overview & Revenue Model

Company DescriptionMexan Limited, an investment holding company, engages in the hotel operation. The company operates with Winland 800 Hotel, which consists of 800 rooms in Tsing Yi, New Territories. It also engages in the property holding, and self-laundry activities. The company was incorporated in 1991 and is based in Tsing Yi, Hong Kong. Mexan Limited is a subsidiary of Winland Wealth (BVI) Limited.
How the Company Makes MoneyMexan generates revenue through a diversified model that includes direct sales of automotive components to original equipment manufacturers (OEMs) and aftermarket retailers. The company capitalizes on long-term contracts with key automotive manufacturers, ensuring a steady stream of income from bulk orders. In addition to direct sales, Mexan also engages in joint ventures and partnerships with technology firms to develop advanced automotive solutions, providing additional revenue through collaborative projects. The company's strong emphasis on research and development allows it to introduce new products that meet industry standards, thereby attracting more clients and expanding its market share.

Mexan Financial Statement Overview

Summary
Weak fundamentals: revenue fell 75% in the latest period and profitability remains poor with consistently negative net income and EBIT margins. The balance sheet leverage appears manageable, and cash flow shows some improvement with positive free cash flow growth, but overall financial health is pressured by ongoing losses and negative ROE.
Income Statement
30
Negative
The income statement reveals significant challenges, with a steep decline in revenue of 75% in the latest period. The company has consistently reported negative net income and EBIT margins, indicating ongoing profitability issues. Despite a positive gross profit margin, the overall financial health is weak due to substantial losses.
Balance Sheet
55
Neutral
The balance sheet shows a moderate debt-to-equity ratio, suggesting manageable leverage. However, the return on equity is negative, reflecting the company's inability to generate profits from its equity base. The equity ratio is stable, indicating a solid asset base, but the negative ROE remains a concern.
Cash Flow
45
Neutral
Cash flow analysis indicates some improvement, with positive free cash flow growth in the latest period. However, the operating cash flow to net income ratio is concerning, as it suggests cash flow issues relative to reported earnings. The free cash flow to net income ratio is positive, indicating some cash generation capability despite losses.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue150.52M37.59M176.94M126.36M27.52M24.49M
Gross Profit48.49M6.93M69.00M44.32M8.66M11.09M
EBITDA8.43M-12.17M13.48M-2.91M-23.39M-23.59M
Net Income-20.49M-32.02M-20.16M-23.77M-44.41M-43.26M
Balance Sheet
Total Assets511.62M546.92M555.23M602.36M536.21M557.98M
Cash, Cash Equivalents and Short-Term Investments39.68M40.30M46.95M50.21M21.38M26.76M
Total Debt93.71M87.70M121.46M119.14M81.74M61.68M
Total Liabilities142.71M199.05M176.41M203.15M113.07M90.23M
Stockholders Equity372.33M351.41M382.16M402.32M426.08M470.49M
Cash Flow
Free Cash Flow24.91M28.71M16.21M-26.61M-25.43M-12.18M
Operating Cash Flow26.94M29.18M18.23M-22.15M-16.46M-11.44M
Investing Cash Flow-1.46M518.00K-1.78M-6.24M-8.97M-737.00K
Financing Cash Flow-46.63M-36.90M-24.01M57.23M20.06M31.17M

Mexan Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price0.21
Price Trends
50DMA
0.17
Positive
100DMA
0.15
Positive
200DMA
0.15
Positive
Market Momentum
MACD
0.01
Positive
RSI
52.93
Neutral
STOCH
25.64
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0022, the sentiment is Neutral. The current price of 0.21 is below the 20-day moving average (MA) of 0.22, above the 50-day MA of 0.17, and above the 200-day MA of 0.15, indicating a neutral trend. The MACD of 0.01 indicates Positive momentum. The RSI at 52.93 is Neutral, neither overbought nor oversold. The STOCH value of 25.64 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:0022.

Mexan Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
HK$368.36M-1.14-4.72%3.58%-91.61%
56
Neutral
HK$635.24M-22.90-0.66%3.97%41.51%
49
Neutral
HK$271.96M-0.16-19.01%-2.75%-17.31%
49
Neutral
HK$157.15M-0.82-4.69%3.58%-87.78%
47
Neutral
HK$399.18M-19.71
40
Neutral
HK$485.34M-0.27-29.62%-0.60%34.74%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:0022
Mexan
0.21
0.19
1378.57%
HK:0219
Shun Ho Property Investments Ltd
0.73
0.16
28.07%
HK:0253
Shun Ho Holdings Ltd
0.65
0.06
10.17%
HK:0201
Magnificent Hotel Investments Limited
0.07
0.00
0.00%
HK:0617
Paliburg Holdings Limited
0.24
-0.31
-56.91%
HK:0078
Regal Hotels International Holdings Limited
0.54
-1.82
-77.12%

Mexan Corporate Events

Mexan Flags Share Price Surge as Controlling Shareholder Reviews Stake
Jan 5, 2026

Mexan Limited has issued a clarification after noting recent sharp increases in its share price and heightened press coverage related to the stake held by its controlling shareholder. Following internal enquiries, the company said it has been informed that the controlling shareholder may be considering a preliminary internal review of its shareholding in Mexan, but stressed that there is currently no information arising from this that requires disclosure under Hong Kong listing rules. The board pledged to continue observing all disclosure obligations and cautioned shareholders and potential investors to exercise care when trading the company’s securities, underscoring that any potential changes in ownership remain at an early and uncertain stage.

The most recent analyst rating on (HK:0022) stock is a Hold with a HK$0.15 price target. To see the full list of analyst forecasts on Mexan stock, see the HK:0022 Stock Forecast page.

Mexan Limited Reports Strong Interim Financial Results
Nov 19, 2025

Mexan Limited has reported its unaudited interim results for the six months ending September 30, 2025, showing significant financial improvement. The company’s revenue increased by 75% to HK$25,079,000, and it achieved a gross profit of HK$8,592,000, a substantial rise from the previous year. The profit attributable to the owners of the company surged to HK$381,746,000, marking a remarkable turnaround from the loss reported in the same period last year. This financial performance highlights Mexan’s strengthened market position and operational efficiency, indicating positive implications for stakeholders.

Mexan Limited Schedules Board Meeting to Approve Interim Results
Nov 5, 2025

Mexan Limited has announced a board meeting scheduled for November 19, 2025, where the interim financial results for the six months ending September 30, 2025, will be approved. This announcement is crucial for stakeholders as it will provide insights into the company’s financial health and operational performance during this period.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 29, 2026